Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling

作者：Ghoreschi Kamran^*; Laurence Arian; Yang Xiang Ping; Tato Cristina M; McGeachy Mandy J; Konkel Joanne E; Ramos Haydee L; Wei Lai; Davidson Todd S; Bouladoux Nicolas; Grainger John R; Chen Qian; Kanno Yuka; Watford Wendy T; Sun Hong Wei; Eberl GerRard; Shevach EthanM; Belkaid Yasmine; Cua Daniel J; Chen WanJun; O'Shea John J

来源：Nature, 2010, 467(7318): 967-U144.

DOI：10.1038/nature09447

CD4(+) T-helper cells that selectively produce interleukin (IL)-17 (T(H)17), are critical for host defence and autoimmunity(1-4). Although crucial for T(H)17 cells in vivo(5,6), IL-23 has been thought to be incapable of driving initial differentiation. Rather, IL-6 and transforming growth factor (TGF)-beta 1 have been proposed to be the factors responsible for initiating specification(7-10). Here we show that T(H)17 differentiation can occur in the absence of TGF-beta signalling. Neither IL-6 nor IL-23 alone efficiently generated T(H)17 cells; however, these cytokines in combination with IL-1 beta effectively induced IL-17 production in naive precursors, independently of TGF-beta. Epigenetic modification of the Il17a, Il17f and Rorc promoters proceeded without TGF-beta 1, allowing the generation of cells that co-expressed ROR gamma t (encoded by Rorc) and T-bet. T-bet(+)ROR gamma t(+) T(H)17 cells are generated in vivo during experimental allergic encephalomyelitis, and adoptively transferred T(H)17 cells generated with IL-23 without TGF-beta 1 were pathogenic in this disease model. These data indicate an alternative mode for T(H)17 differentiation. Consistent with genetic data linking IL23R with autoimmunity, our findings re-emphasize the importance of IL-23 and therefore may have therapeutic implications.

• 出版日期2010-10-21